References
- Lassen D, Damkier P, Brosen K. The pharmacogenetics of tramadol. Clin Pharmacokinet 2015; 54: 825-36. https://doi.org/10.1007/s40262-015-0268-0
- Farquhar-Smith P, Gubbay A. Tramadol and acetaminophen combination for chronic non-cancer pain. Expert Opin Pharmacother 2013; 14: 2297-304. https://doi.org/10.1517/14656566.2013.839985
- Kress HG. Tapentadol and its two mechanisms of action: is there a new pharmacological class of centrally-acting analgesics on the horizon? Eur J Pain 2010; 14: 781-3. https://doi.org/10.1016/j.ejpain.2010.06.017
- Dart RC, Bartelson BB, Adams EH. Nonmedical use of tapentadol immediate release by college students. Clin J Pain 2014; 30: 685-92. https://doi.org/10.1097/AJP.0000000000000001
- Dart RC, Cicero TJ, Surratt HL, Rosenblum A, Bartelson BB, Adams EH. Assessment of the abuse of tapentadol immediate release: the first 24 months. J Opioid Manag 2012; 8: 395-402. https://doi.org/10.5055/jom.2012.0139
- Buschmann H. Chapter 12 Tapentadol - from morphine and tramadol to the discovery of tapentadol. In: Analogue-based drug discovery III. Edited by Fischer J, Ganellin CR, Rotella DP. Weinheim, Wiley-VCH. 2013, pp 295-318.
- Wade WE, Spruill WJ. Tapentadol hydrochloride: a centrally acting oral analgesic. Clin Ther 2009; 31: 2804-18. https://doi.org/10.1016/j.clinthera.2009.12.003
- Smyth LA, Collins I. Measuring and interpreting the selectivity of protein kinase inhibitors. J Chem Biol 2009; 2: 131-51. https://doi.org/10.1007/s12154-009-0023-9
- Tzschentke TM, Folgering JH, Flik G, De Vry J. Tapentadol increases levels of noradrenaline in the rat spinal cord as measured by in vivo microdialysis. Neurosci Lett 2012; 507: 151-5. https://doi.org/10.1016/j.neulet.2011.12.008
- Ramaswamy S, Chang S, Mehta V. Tapentadol--the evidence so far. Anaesthesia 2015; 70: 518-22. https://doi.org/10.1111/anae.13080
- Ok YM, Cheon JH, Choi EJ, Chang EJ, Lee HM, Kim KH. Nefopam reduces dysesthesia after percutaneous endoscopic lumbar discectomy. Korean J Pain 2016; 29: 40-7. https://doi.org/10.3344/kjp.2016.29.1.40
- Kim KH, Abdi S. Rediscovery of nefopam for the treatment of neuropathic pain. Korean J Pain 2014; 27: 103-11. https://doi.org/10.3344/kjp.2014.27.2.103
- Barber J. Examining the use of tramadol hydrochloride as an antidepressant. Exp Clin Psychopharmacol 2011; 19: 123-30. https://doi.org/10.1037/a0022721
- Terlinden R, Ossig J, Fliegert F, Lange C, Gohler K. Absorption, metabolism, and excretion of 14C-labeled tapentadol HCl in healthy male subjects. Eur J Drug Metab Pharmacokinet 2007; 32: 163-9. https://doi.org/10.1007/BF03190478
- Singh DR, Nag K, Shetti AN, Krishnaveni N. Tapentadol hydrochloride: a novel analgesic. Saudi J Anaesth 2013; 7: 322-6. https://doi.org/10.4103/1658-354X.115319
- Park CH. Comparison of morphine and tramadol in transforaminal epidural injections for lumbar radicular pain. Korean J Pain 2013; 26: 265-9. https://doi.org/10.3344/kjp.2013.26.3.265
- Xu XS, Smit JW, Lin R, Stuyckens K, Terlinden R, Nandy P. Population pharmacokinetics of tapentadol immediate release (IR) in healthy subjects and patients with moderate or severe pain. Clin Pharmacokinet 2010; 49: 671-82. https://doi.org/10.2165/11535390-000000000-00000
- Afilalo M, Etropolski MS, Kuperwasser B, Kelly K, Okamoto A, Van Hove I, et al. Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled phase III study. Clin Drug Investig 2010; 30: 489-505. https://doi.org/10.2165/11533440-000000000-00000
- Cepeda MS, Fife D, Ma Q, Ryan PB. Comparison of the risks of opioid abuse or dependence between tapentadol and oxycodone: results from a cohort study. J Pain 2013; 14: 1227-41. https://doi.org/10.1016/j.jpain.2013.05.010
- Cepeda MS, Fife D, Vo L, Mastrogiovanni G, Yuan Y. Comparison of opioid doctor shopping for tapentadol and oxycodone: a cohort study. J Pain 2013; 14: 158-64. https://doi.org/10.1016/j.jpain.2012.10.012
- Dart RC, Surratt HL, Le Lait MC, Stivers Y, Bebarta VS, Freifeld CC, et al. Diversion and illicit sale of extended release tapentadol in the United States. Pain Med. Forthcoming 2015.
- Butler SF, McNaughton EC, Black RA. Tapentadol abuse potential: a postmarketing evaluation using a sample of individuals evaluated for substance abuse treatment. Pain Med 2015; 16: 119-30. https://doi.org/10.1111/pme.12524
- McNaughton EC, Black RA, Weber SE, Butler SF. Assessing abuse potential of new analgesic medications following market release: an evaluation of internet discussion of tapentadol abuse. Pain Med 2015; 16: 131-40. https://doi.org/10.1111/pme.12547
-
Vosburg SK, Jones JD, Manubay JM, Ashworth JB, Shapiro DY, Comer SD. A comparison among tapentadol tamperresistant formulations (TRF) and
$OxyContin^{(R)}$ (non-TRF) in prescription opioid abusers. Addiction 2013; 108: 1095-106. https://doi.org/10.1111/add.12114
Cited by
- Comparative pharmacology and toxicology of tramadol and tapentadol vol.22, pp.5, 2018, https://doi.org/10.1002/ejp.1196
- Cardiac Arrest Following Drug Abuse with Intravenous Tapentadol: Case Report and Literature Review vol.18, pp.None, 2016, https://doi.org/10.12659/ajcr.904695
- Opioid-induced constipation: a narrative review of therapeutic options in clinical management vol.32, pp.2, 2019, https://doi.org/10.3344/kjp.2019.32.2.69
- Tapentadol, the new kid on the block in India: Is it time to worry? vol.62, pp.6, 2020, https://doi.org/10.4103/psychiatry.indianjpsychiatry_332_20
- Dual μ-opioid receptor and norepinephrine reuptake mechanisms contribute to dezocine- and tapentadol-induced mechanical antiallodynia in cancer pain vol.876, pp.None, 2016, https://doi.org/10.1016/j.ejphar.2020.173062
- Repeated Administration of Clinical Doses of Tramadol and Tapentadol Causes Hepato- and Nephrotoxic Effects in Wistar Rats vol.13, pp.7, 2020, https://doi.org/10.3390/ph13070149
- Sublingual delivery of chondroitin sulfate conjugated tapentadol loaded nanovesicles for the treatment of osteoarthritis vol.31, pp.1, 2021, https://doi.org/10.1080/08982104.2020.1730400